- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
News Release
The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City,...
Showing 10 out of 1514 results
|
NHLBI in the Press
A small study found that young adults with heritable forms of hypertrophic cardiomyopathy who received valsartan, a drug used to treat high blood pressure and heart failure, tolerated the treatment and were less likely to experience changes in cardiovascular structure and function.
|
NHLBI in the Press
Adults with normal blood pressure and high levels of stress hormones are more likely to develop high blood pressure and experience cardiovascular events, study says.
|
NHLBI in the Press
After studying lung infection rates among New York City firefighters who served as first responders at the World Trade Center on Sept. 11, 2001 and were exposed to tiny air pollution particles, researchers identified factors that overlapped with lung infection risks.
|
NHLBI in the Press
A phase 3 trial found using colchicine reduced death and hospitalization rates among adults with COVID-19 recovering at home, but only if they had a positive test result. More research is necessary to assess the benefits of using this anti-inflammatory treatment for moderate COVID-19 cases.
|
NHLBI in the Press
Moving more and sitting less were factors associated with a reduced likelihood of developing obstructive sleep apnea among thousands of health care providers.
|
NHLBI in the Press
Lung ultrasound did not help emergency departments (EDs) manage acute heart failure patients in their initial hours of presenting with symptoms, according to the findings of a randomized pilot trial.
Credit: NIH Image Gallery
|
NHLBI in the Press
A phase 2 study with 59 patients found fostamatinib, a targeted immune therapy used for a rare bleeding disorder, did not result in more adverse outcomes among adults hospitalized for COVID-19 who required assisted breathing support.
|
NHLBI in the Press
After following more than 123,000 women, ages 50-79, for 15 years, researchers found that those who ate a higher proportion of plant-based foods with healthful fats had a reduced risk for cardiovascular disease, coronary heart disease, and heart failure.